These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 18407135)

  • 1. The molecular basis of a hereditary form of hypertension, glucocorticoid-remediable aldosteronism.
    Lifton RP; Dluhy RG
    Trends Endocrinol Metab; 1993 Mar; 4(2):57-61. PubMed ID: 18407135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoid-remediable aldosteronism.
    Dluhy RG; Lifton RP
    Endocrinol Metab Clin North Am; 1994 Jun; 23(2):285-97. PubMed ID: 8070423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension.
    Lifton RP; Dluhy RG; Powers M; Rich GM; Cook S; Ulick S; Lalouel JM
    Nature; 1992 Jan; 355(6357):262-5. PubMed ID: 1731223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary hypertension caused by chimaeric gene duplications and ectopic expression of aldosterone synthase.
    Lifton RP; Dluhy RG; Powers M; Rich GM; Gutkin M; Fallo F; Gill JR; Feld L; Ganguly A; Laidlaw JC
    Nat Genet; 1992 Sep; 2(1):66-74. PubMed ID: 1303253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Chinese pedigree with glucocorticoid remediable aldosteronism.
    Liu X; Jin L; Zhang H; Ma W; Song L; Zhou X; Cai J
    Hypertens Res; 2021 Nov; 44(11):1428-1433. PubMed ID: 34462604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoid-remediable aldosteronism.
    Halperin F; Dluhy RG
    Endocrinol Metab Clin North Am; 2011 Jun; 40(2):333-41, viii. PubMed ID: 21565670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoid remediable aldosteronism: a case report.
    Hsieh CJ; Wang PW; Liu JC; Tung SC; Chien WY; Lu YC; Kuo MC
    Changgeng Yi Xue Za Zhi; 1997 Mar; 20(1):52-7. PubMed ID: 9178594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic screening for glucocorticoid-remediable aldosteronism (GRA): experience of three clinical centres in Poland.
    Adler G; Widecka K; Peczkowska M; Dobrucki T; Placha G; Drozd R; Parczewski M; Januszewicz A; Gaciong Z; Ciechanowicz A
    J Appl Genet; 2005; 46(3):329-32. PubMed ID: 16110193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocorticoid-remediable aldosteronism (GRA): diagnosis, variability of phenotype and regulation of potassium homeostasis.
    Dluhy RG; Lifton RP
    Steroids; 1995 Jan; 60(1):48-51. PubMed ID: 7792815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormality of aldosterone and cortisol late pathways in glucocorticoid-remediable aldosteronism.
    Fallo F; Kuhnle U; Boscaro M; Sonino N
    J Clin Endocrinol Metab; 1994 Sep; 79(3):772-4. PubMed ID: 8077359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial hyperaldosteronism.
    Torpy DJ; Stratakis CA; Chrousos GP
    Braz J Med Biol Res; 2000 Oct; 33(10):1149-55. PubMed ID: 11004715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoid-remediable aldosteronism.
    Williams GH; Dluhy RG
    J Endocrinol Invest; 1995; 18(7):512-7. PubMed ID: 9221269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aldosterone-producing adenomas do not contain glucocorticoid-remediable aldosteronism chimeric gene duplications.
    Carroll J; Dluhy R; Fallo F; Pistorello M; Bradwin G; Gomez-Sanchez CE; Mortensen R
    J Clin Endocrinol Metab; 1996 Dec; 81(12):4310-2. PubMed ID: 8954032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New genetic insights in familial hyperaldosteronism.
    Jackson RV; Lafferty A; Torpy DJ; Stratakis C
    Ann N Y Acad Sci; 2002 Sep; 970():77-88. PubMed ID: 12381543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and gene mutation studies on a Chinese pedigree with glucocorticoid-remediable aldosteronism.
    Ding W; Liu L; Hu R; Xu M; Chen J
    Chin Med J (Engl); 2002 Jul; 115(7):979-82. PubMed ID: 12150724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Juvenile hypertension, the role of genetically altered steroid metabolism.
    Ferrari P; Bianchetti M; Frey FJ
    Horm Res; 2001; 55(5):213-23. PubMed ID: 11740142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoid-remediable aldosteronism.
    McMahon GT; Dluhy RG
    Cardiol Rev; 2004; 12(1):44-8. PubMed ID: 14667264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic study of patients with dexamethasone-suppressible aldosteronism without the chimeric CYP11B1/CYP11B2 gene.
    Fardella CE; Pinto M; Mosso L; Gómez-Sánchez C; Jalil J; Montero J
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4805-7. PubMed ID: 11600544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocorticoid remediable aldosteronism: low morbidity and mortality in a four-generation italian pedigree.
    Mulatero P; di Cella SM; Williams TA; Milan A; Mengozzi G; Chiandussi L; Gomez-Sanchez CE; Veglio F
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3187-91. PubMed ID: 12107222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the dexamethasone suppression test for the diagnosis of glucocorticoid-remediable aldosteronism.
    Litchfield WR; New MI; Coolidge C; Lifton RP; Dluhy RG
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3570-3. PubMed ID: 9360508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.